Forte Biosciences, Inc.

NASDAQ:FBRX

7.005 (USD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q12017 Q12001 Q1
Operating Activities:
Net Income -12.511-7.42-5.872-9.955-8.896-6.753-4.877-3.4-3.035-2.567-3.341-7.751-5.812-4.804-4.576-5.1-34.761-2.05-1.564-0.69-0.63-1.185-24.435-12.88-9.073-2.567
Depreciation & Amortization 0.010.0090.0060.00300000000.0090.0130.0140.0140.0130.0140.0130.01100.2170.2160.510.0490.0660
Deferred Income Tax 00-4.658-0.00300000000003.831000-8.05800-2-1.2560.1791.0770
Stock Based Compensation 0.8020.8050.780.7720.8550.8770.860.9061.1941.0551.2381.4731.0080.4950.5550.3750.0240.0020.0310.0020.0010.0023.7651.5210.5291.055
Change In Working Capital 5.768-0.055-3.8910.242.5870.6721.1240.5540.464-0.463-1.4791.0810.8530.2650.204-3.027-0.178-0.830.1250.1350.0580.0651.626-0.179-1.077-0.37
Accounts Receivables 00000000000000000000000000
Change In Inventory 00000000000000000000000000
Change In Accounts Payables 3.590.261-3.8662.2841.6640.1890.0180.4660.093-0.37-1.3841.345-0.221-0.0340.025-1.3531.859-0.9-0.9250.1080.285-0.492.886-0.179-1.077-0.37
Other Working Capital 2.178-0.316-0.025-2.0440.923-0.1891.1060.0880.371-0.093-0.095-0.2641.0740.2990.179-1.674-2.0370.070.1250.0270.0580.065-1.6260.1791.0770.37
Other Non Cash Items -2.7730.5564.666-0.115-0.0210.6880.8420.441.1011.4252.6220.0611.2550.557-3.831-1.35330.885-0.90.7440.108-0.6190.7437.571-1.3980.911-0.093
Operating Cash Flow -5.936-6.667-8.969-9.058-5.475-5.204-2.893-1.94-1.377-1.975-3.582-5.127-3.938-4.03-3.803-7.739-4.016-2.865-0.653-0.553-1.19-0.375-12.219-12.708-7.567-1.975
Investing Activities:
Investments In Property Plant And Equipment 0-0.006-0.017-0.0710000000.0610000000-0.089-0.073-0.124-0.133-1.695-0.22-0.0530
Acquisitions Net 000000000000000-0.0013.5830-42.13900-6.230000
Purchases Of Investments 0000-9.9650000000000000-51.16300-21.606-48.469-12.528-9.7490
Sales Maturities Of Investments 000.00110.099000000000000012.72293.4730027.83645.8849.08713.5530
Other Investing Activites 0000.01-0.0100000-0.0610003.583-0.0010017.272-0.073-0.2826.23-0.0200.020
Investing Cash Flow 0-0.006-0.01610.028-9.965000000.0610003.583-0.0013.58312.722-0.089-0.073-0.4066.097-4.3-3.6613.7710
Financing Activities:
Debt Repayment 00000000000000000000000000
Common Stock Issued 00.008-0.06324.825-0.0240.006-0.0557.28400.0120.0620.0190.0150.02742.683000.010.551000.2480.5910.0290.0410
Common Stock Repurchased 0-0.016-0-0-00-000000000000-8.2370000000
Dividends Paid 00000000000000000000000000
Other Financing Activities -0.01-0.016-0.012-0.0480000.156-0.11-0.034-0.101-0.003-0.0290.027-0.290.16624.0630.035-15.459004.85639.512-1.85.2-0.034
Financing Cash Flow -0.01-0.008-0.07524.777-0.0240.006-0.0557.44-0.11-0.034-0.039-0.003-0.0290.02742.3930.16624.0630.045-23.145004.85640.103-1.7715.241-0.034
Other Information:
Effect Of Forex Changes On Cash 00-0.1230000000-0.061000-3.58300-12.722-000-40.8130000
Net Change In Cash -1.059-1.326-9.18325.747-15.464-5.198-2.9485.5-1.487-2.009-3.621-5.13-3.967-4.00338.59-7.57423.63-2.82-0.742-0.626-1.19-31.31623.02-18.141.445-2.009
Cash At End Of Period 9.57610.63511.96146.18520.43835.90241.144.04838.54840.03542.04445.66550.79554.76258.76520.17527.7494.1196.9397.6818.3079.49740.81317.7936.95540.035